지원사업
학술연구/단체지원/교육 등 연구자 활동을 지속하도록 DBpia가 지원하고 있어요.
커뮤니티
연구자들이 자신의 연구와 전문성을 널리 알리고, 새로운 협력의 기회를 만들 수 있는 네트워킹 공간이에요.
이용수
등록된 정보가 없습니다.
논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!
Long-term effects of gonadotropin-releasing hormone analogs in girls with central precocious puberty
Clinical and Experimental Pediatrics
2015 .01
Treatment outcomes of gonadotropin-releasing hormone agonist in obese girls with central precocious puberty
Annals of Pediatirc Endocrinology & Metabolism
2017 .01
Long-term efficacy of a triptorelin 3-month depot in girls with central precocious puberty
Annals of Pediatirc Endocrinology & Metabolism
2024 .06
Comparing adult height gain and menarcheal age between girls with central precocious puberty treated with gonadotropin-releasing hormone agonist alone and those treated with combined growth hormone therapy
Annals of Pediatirc Endocrinology & Metabolism
2019 .01
Bilateral Salpingo-oophorectomy Compared to Gonadotropin-Releasing Hormone Agonists in Premenopausal Hormone Receptor–Positive Metastatic Breast Cancer Patients Treated with Aromatase Inhibitors
Cancer Research and Treatment
2017 .01
The Use of Gonadotropin-Releasing Hormone Agonist Does Not Affect the Development of Cardiovascular Disease in Prostate Cancer Patients: a Nationwide Population-Based Cohort Study
Journal of Korean Medical Science
2020 .01
A Study on Dietary Habits and Lifestyle of Girls with PrecociousPuberty
Pediatric Gastroenterology, Hepatology & Nutrition
2016 .01
Comparison of the clinical outcome of frozen-thawed embryo transfer with and without pretreatment with a gonadotropin-releasing hormone agonist
Obstetrics & Gynecology Science
2018 .01
Changes in body mass index in boys with central precocious puberty over 2 years of gonadotropin-releasing hormone agonist therapy
Annals of Pediatirc Endocrinology & Metabolism
2020 .01
Change in body mass index and insulin resistance after 1-year treatment with gonadotropin-releasing hormone agonists in girls with central precocious puberty
Annals of Pediatirc Endocrinology & Metabolism
2017 .01
The different effects of gonadotropin-releasing hormone agonist therapy on body mass index and growth between normal-weight and overweight girls with central precocious puberty
Annals of Pediatirc Endocrinology & Metabolism
2017 .01
Efficacy of Triptorelin 3-Month Depot Compared to 1-Month Depot for the Treatment of Korean Girls with Central Precocious Puberty in Single Tertiary Center
Journal of Korean Medical Science
2021 .08
Clinical findings influencing time to menarche post gonadotropin-releasing hormone agonist therapy in central precocious puberty
Annals of Pediatirc Endocrinology & Metabolism
2021 .09
Association between different dual trigger dosages and in vitro fertilization results in patients with patientoriented strategies encompassing individualized oocyte number group IV
Obstetrics & Gynecology Science
2022 .03
Does coronavirus disease 2019 affect body mass index of children and adolescents who visited a growth clinic in South Korea?: a single-center study
Annals of Pediatirc Endocrinology & Metabolism
2022 .03
Serum Anti-Müllerian Hormone Levels in Precocious Puberty Girls according to Stage of GnRH Agonist Treatment
Journal of Korean Medical Science
2017 .01
Relationship between final adult height and birth weight after gonadotropin-releasing hormone agonist treatment in girls with central precocious puberty
Annals of Pediatirc Endocrinology & Metabolism
2020 .01
Relationship between growth velocity and change of levels of insulin-like growth factor-1, insulin-like growth factor binding protein-3 and, IGFBP-3 promoter polymorphism during GnRH agonist treatment
Annals of Pediatirc Endocrinology & Metabolism
2020 .01
Effect of gonadotropin-releasing hormone agonist treatment on near final height in girls with central precocious puberty and early puberty
Annals of Pediatirc Endocrinology & Metabolism
2023 .03
Commentary on "Effect of gonadotropin-releasing hormone agonist treatment on near final height in girls with central precocious puberty and early puberty"
Annals of Pediatirc Endocrinology & Metabolism
2023 .03
0